AKAP6 Polyclonal Antibody

The A-kinase anchor proteins (AKAPs) are a group of structurally diverse proteins, which have the common function of binding to the regulatory subunit of protein kinase A (PKA) and confining the holoenzyme to discrete locations within the cell. This gene encodes a member of the AKAP family. The encoded protein is highly expressed in various brain regions and cardiac and skeletal muscle. It is specifically localized to the sarcoplasmic reticulum and nuclear membrane, and is involved in anchoring PKA to the nuclear membrane or sarcoplasmic reticulum.

The AKAP6 Polyclonal Antibody is a highly specific and reliable tool designed for the detection and analysis of A-kinase anchor protein 6 (AKAP6) in various biological samples. This antibody has been meticulously developed using advanced immunization techniques and exhibits exceptional sensitivity and specificity towards AKAP6.

AKAP6 is a crucial protein that plays a pivotal role in the regulation of protein kinase A (PKA) signaling pathway. It acts as a scaffold protein, facilitating the assembly of PKA and other signaling molecules, thereby ensuring the precise spatiotemporal control of PKA activity. AKAP6 has been implicated in numerous cellular processes, including cardiac function, neuronal signaling, and cell cycle regulation.

The AKAP6 Polyclonal Antibody demonstrates outstanding performance in various applications, including Western blotting, immunohistochemistry, and immunofluorescence. It exhibits minimal cross-reactivity with other related proteins, ensuring accurate and reliable results. This antibody is suitable for use in both research and clinical settings, enabling the investigation of AKAP6 expression and localization in diverse biological contexts.

With its high affinity and specificity, the AKAP6 Polyclonal Antibody offers researchers a valuable tool for studying the intricate mechanisms underlying PKA signaling and its involvement in various physiological and pathological processes. Its exceptional performance and reliability make it an indispensable asset for scientists and clinicians alike, facilitating advancements in the understanding and treatment of diseases associated with dysregulated PKA signaling.